ZUBQUTAY Trademark

Prosecution Summary

Trademark Summary
The standard character mark ZUBQUTAY covers pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders in International Class 005, including anti-infectives, medicated dermatological preparations, antifungal preparations, smoking cessation preparations, and vaccines, along with goods/services in domestic classes 006, 018, 044, 046, 051, and 052. The application is pending examination with a non-final Office action issued on February 4, 2026, requiring a response from the applicant. It is owned by Pfizer Inc., a Delaware corpora

Trademark Facts

Goods & Services

Class 005: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use

Recent Prosecution Activity

USPTO Refusals on Record

• domicile_required

Related

• All trademarks from Pfizer Inc.
• More marks in Class 005
• Search for similar marks to ZUBQUTAY
• Run a clearance check
• Free USPTO trademark search